JIANGSU SIHUAN BIOENGINEERING CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.12 CNY | +1.44% |
|
-0.47% | -36.14% |
| Sales 2021 | 340M 46.98M | Sales 2022 | 270M 37.32M | Capitalization | 3.26B 451M |
|---|---|---|---|---|---|
| Net income 2021 | -34M -4.7M | Net income 2022 | -48M -6.63M | EV / Sales 2021 | 11 x |
| Net Debt 2021 | 12.77M 1.76M | Net Debt 2022 | 20.41M 2.82M | EV / Sales 2022 | 12.2 x |
| P/E ratio 2021 |
-107
x | P/E ratio 2022 |
-66.9
x | Employees | 250 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 58.61% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.44% | ||
| 1 week | -0.47% | ||
| Current month | -19.39% | ||
| 1 month | -19.39% | ||
| 3 months | -26.90% | ||
| 6 months | -22.34% | ||
| Current year | -36.14% |
1 week
2.01
2.15
1 month
2.002.81
Current year
1.723.48
1 year
1.724.57
3 years
1.724.57
5 years
1.728.83
10 years
1.729.77
| Managers | Title | Age | Since |
|---|---|---|---|
Yu Guo
CEO | Chief Executive Officer | 36 | 20-06-18 |
Hai Zhen Xu
DFI | Director of Finance/CFO | 46 | 17-06-08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yu Lu
BRD | Director/Board Member | 49 | 23-06-25 |
Wei Liu
BRD | Director/Board Member | 62 | - |
Xiao Li Gong
BRD | Director/Board Member | 35 | 17-01-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 2.12 | +1.44% | 12 207 300 |
| 24-04-24 | 2.09 | +0.48% | 7,691,400 |
| 24-04-23 | 2.08 | +1.96% | 9,868,701 |
| 24-04-22 | 2.04 | -1.45% | 10,018,500 |
| 24-04-19 | 2.07 | -0.96% | 9,832,290 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
JIANGSU SIHUAN BIOENGINEERING CO., LTD is a China-based company principally engaged in the research, development, manufacture and distribution of medicines and health supplements. The Companyâs main products include interleukin, erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), tablets, bulk drugs, infusion glass bottles, soft bag infusion, syrup and healthcare products, among others. The Company is also engaged in landscape engineering, maintenance projects, the sale of nursery stocks and other businesses. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-24
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -36.14% | 297M | |
| -2.86% | 87.31B | |
| +2.63% | 40.86B | |
| -21.76% | 29.36B | |
| +58.56% | 24.49B | |
| -14.78% | 17.31B | |
| -18.49% | 11.62B | |
| -15.61% | 11.31B | |
| -44.02% | 11.26B | |
| +5.17% | 8.31B |
- Stock Market
- Equities
- 000518 Stock
